Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

9 Apr 2020 10:21

RNS Number : 3649J
Mandarin Oriental International Ltd
09 April 2020
 

The following announcement has been issued to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

9th April 2020 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2020.

 

The Group's performance was severely impacted by the COVID-19 pandemic, resulting in an unaudited underlying loss of some US$40 million in the first quarter. A majority of the Group's hotels are now effectively closed and, while most hotels in Asia remain open, they are experiencing single digit percentage occupancy levels.

 

The Group has taken a number of actions to manage costs and preserve cash. These include the suspension of non-essential expenses and capital expenditure, significantly reducing payroll costs through unpaid leave, furloughing, substantial voluntary salary reductions at all levels and participation in government support measures wherever possible. The payroll measures have been taken proportionate to the seniority and means of colleagues. The Directors would like to express their deep gratitude for the continuing dedication and resolve of colleagues during these difficult times.

 

It is too early to forecast the duration of the impact of COVID-19 on the business but, as a result of the substantial reduction in revenue and management fees from the Group's hotels, the underlying loss in the second quarter is expected to be larger than in the first quarter.

 

In light of the exceptional circumstances, the Directors have withdrawn their recommendation of a final dividend in respect of the 2019 financial year and the relevant resolution seeking approval for the payment of the dividend will no longer be put to shareholders at the Company's AGM on 6th May 2020.

 

The Group's balance sheet and liquidity position both remain strong and will enable it to sustain the current low levels of business activity for an extended period of time. At 31st March 2020, net debt was US$363 million compared to net debt of US$300 million at the end of 2019. Gearing was 6% of adjusted shareholders' funds. During the quarter, the Group invested US$19 million in the restoration of Mandarin Oriental Ritz, Madrid.

 

At 31st March 2020, in addition to US$229 million of cash reserves, the Group also had US$207 million in available debt facilities that are committed for four years. The Group's facilities are not subject to any cash flow covenants.

 

While the Group's operations are currently being dramatically impacted by events associated with the COVID-19 pandemic, Mandarin Oriental remains a powerful brand that is well positioned to benefit over the long-term, when demand for luxury travel returns.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

Brunswick Group Limited

David Ashton (852) 3512 5063

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKLBBBZLFBBV
Date   Source Headline
19th Jan 20261:45 pmRNSCompletion of Acquisition by Jardine Strategic
16th Jan 20267:00 amRNSCourt Sanction of Scheme of Arrangement
9th Jan 20269:19 amRNSOCB Dividend
31st Dec 20257:22 amRNSUpdate on OCB Sale and Acquisition Timeline
31st Dec 20257:22 amRNSUpdate on OCB Sale and Acquisition Timeline
8th Dec 20253:47 pmRNSResults of Court Meeting & Special General Meeting
21st Nov 20259:58 amRNSInterim Management Statement
14th Nov 202511:37 amRNSReplacement: Publication of Shareholder Circular
14th Nov 20259:38 amRNSAnnouncement (Publication of Shareholder Circular)
17th Oct 202510:24 amRNSRecommended Cash Acquisition of Mandarin Oriental
17th Oct 202510:21 amRNSSale of 301,555 sq.ft. of One Causeway Bay
2nd Oct 202510:20 amRNSDividend Declaration
30th Sep 20257:00 amRNSRESPONSE TO MEDIA SPECULATION
25th Sep 202510:23 amRNSBlock listing Interim Review
28th Jul 202512:33 pmRNSHalf-year Results
11th Jul 202510:28 amRNSNotification to Untraced Shareholders
15th May 202511:44 amRNSINTERIM MANAGEMENT STATEMENT
2nd May 20251:02 pmRNSResult of AGM
30th Apr 202510:24 amRNSDividend Declaration
7th Apr 202510:39 amRNSAnnual Financial Report
25th Mar 20259:20 amRNSBlock listing Interim Review
5th Mar 20251:42 pmRNS2024 PRELIMINARY RESULTS
14th Nov 20249:43 amRNSINTERIM MANAGEMENT STATEMENT
4th Nov 20249:22 amRNSDirectorate Change
2nd Oct 202410:26 amRNSDividend Declaration
25th Sep 202410:19 amRNSBlock listing Interim Review
31st Jul 202410:17 amRNSCompany Board Change
24th Jul 20243:06 pmRNSHalf-year Report
16th Jul 202410:49 amRNSCompany Board Changes
12th Jun 202411:59 amRNSDisposal
23rd May 202410:44 amRNSINTERIM MANAGEMENT STATEMENT
8th May 202412:38 pmRNSResult of AGM
2nd May 202410:23 amRNSDividend Declaration
9th Apr 202410:28 amRNSAnnual Financial Report
25th Mar 20249:26 amRNSBLOCK LISTING INTERIM REVIEW
7th Mar 202410:04 amRNS2023 Preliminary Results
1st Mar 20249:25 amRNSCHANGE OF SINGAPORE BRANCH REGISTRAR
22nd Dec 20231:18 pmRNSMO Signs Option to sell MO, Paris
24th Nov 20239:22 amRNSDirectorate Change
9th Nov 20239:54 amRNSINTERIM MANAGEMENT STATEMENT
27th Sep 202310:28 amRNSDividend Declaration
25th Sep 202310:33 amRNSBlock listing Interim Review
1st Sep 202310:27 amRNSDirector Declaration
28th Jul 202310:33 amRNSHalf-year Results
18th May 202310:23 amRNSInterim Management Statement
4th May 202312:31 pmRNSResult of AGM
2nd May 202310:17 amRNSDirectorate Change
3rd Apr 202310:26 amRNSAnnual Financial Report
31st Mar 202310:24 amRNSTotal Voting Rights
27th Mar 202310:30 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.